Beruflich Dokumente
Kultur Dokumente
_ + _
Sent
home and
+ _ _ PUI No Monitor
for 21
days
+ + _
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Public Health Action for PUIs
Falls into three general areas
Monitoring
Activity restrictions
Travel restrictions
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Public Health Action for PUIs
The higher the category of risk, the more intense is
monitoring and higher are restrictions on activity and
travel
Unprotected contact with confirmed EVD case = high
risk
HCWs employed in Ebola Treatment Center (ETC) =
some risk
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Public Health Action for PUIs
The higher the category of risk, the more intense is
monitoring and higher are restrictions on activity and
travel
Laboratory scientist doing diagnostic testing = low
risk
Person visiting countries with intense and widespread
transmission but no contact with EVD = low risk
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Monitoring
Checking temperature, other symptoms and signs at
least once a day for 21 days from last contact with EVD
case
Maybe by health professional or Self monitoring
If self monitoring, use phone monitoring with daily check
in
High risk contact checked by HCW twice a day
Low risk self monitoring with phone checking
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Monitoring of PUIs
The following persons are NOT at risk of getting Ebola:
Those who have been in a country with widespread
Ebola transmission (Guinea, Sierra Leone, Liberia) or
Mali
Since MORE THAN 21 days ago
With NO symptoms of Ebola since leaving any of
these countries
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Monitoring of PUIs
The following persons are NOT at risk of getting Ebola:
Aircraft or ship crew members who did not leave the
immediate area of the airplane/ship and had no direct
contact with anyone from the community during the
entire time that they were present in a country with
widespread EVD transmission
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Monitoring of PUIs
The following persons are NOT at risk of getting Ebola:
Contact with a healthy person with NO symptoms
who had contact with a person with Ebola
Contact with a person with Ebola BEFORE the
person developed symptoms
Those who have been in places WITHOUT
widespread EVD transmission (Spain, Texas, New
York)
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Monitoring of PUIs
People with MODERATE RISK:
Direct contact, while using appropriate PPE, with a
person with Ebola who has symptoms, or with the
persons body fluids.
Directly took care of patients in other health care
facilities
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Monitoring of PUIs
People with MODERATE RISK:
With close contact in households, health care
facilities, or the community, WITHOUT appropriate
PPE, with a person with Ebola who has symptoms.
Close contact means being within approximately 3
feet (1 meter) of a person with Ebola for a long time
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Monitoring of PUIs
People at HIGH RISK
Exposed to blood or body fluids of a person with
Ebola who has symptoms, through broken skin (like a
wound or a needle prick) or mucus membranes (such
as splashes to the eyes, nose or mouth)
Exposed to the blood or body fluids (including but not
limited to feces, saliva, sweat, urine, vomit, breast
milk and semen) of a person with Ebola who has
symptoms while not wearing appropriate PPE.
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Monitoring of PUIs
People at HIGH RISK
Processed blood or body fluids of a person with
Ebola who has symptoms without appropriate PPE or
standard biosafety precautions.
Direct contact with a dead body without appropriate
PPE.
Those who live in the immediate household and
provided direct care to a person with Ebola who has
symptoms.
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Activity and travel restrictions options
Restricted public activities
Total quarantine in a designated place
Home quarantine
Total no movement outside home
Partial no public gatherings, but can walk in
parks on isolated streets alone
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Activity and travel restrictions options
Restricted travel
No travel at all
No air travel
No travel on public transport
No moving away from district of quarantine
Free to move
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Monitoring of PUIs
PUI symptomatic suspect isolate admit
Isolation precaution at once
Isolate yourself inside a room
No kissing, hugging or laying of hands
Avoiding contact with body fluids
Immediately place all used clothes and linens in a
plastic bag. DO NOT dispose of this yourself, but
inform DOH regarding its disposal.
Inform DOH immediately.
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Guidelines in testing and disposition of patients
Any
Travel Contact Testing
symptoms Assessment Disposition
history history present for EVD
_ + + Admit to
single
Suspect room.
+ _ + Yes
EVD case Manage
appropriat
+ + + ely
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Isolation/Holding area
This is the area where patients wait while transfer to the
referral hospital is being coordinated
Provide surgical masks to the patients and as much as
possible minimize contact with tem unless deemed
necessary
Should be a separate room located near the triage area
to ensure quick transfer of suspects and to minimize
contact with other hospital patients
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE
Person Under Investigation (PUI)
Any person arriving in the Philippines from any of the
following countries in West Africa, namely; Guinea,
Liberia, Sierra Leone in the past 21 days
OR
OR
EXPOSURE
SYMPTOMS
Virus enters through nose, Survivors (30% in 2014) improve
WORSEN
mouth, eyes, ears, breaks in after 6 days of symptoms Around 2 weeks after
skin
exposure, patients
SPREAD develop diarrhea,
vomiting, abdominal
In the West African outbreak, each DEATH pain, rash, red eyes,
person with Ebola infects 1.7-2 6-16 days after symptoms begin (avg. 7.5 in 2014), bleeding
others. Ebola patients are most damage to blood vessels causes drop in blood
contagious at and near death pressure and organ failure
SCREENING AND
TRIAGE FOR EBOLA
VIRUS DISEASE